T cell derived cytokines in psoriatic arthritis synovial fluids.
about
Dipeptidyl peptidase IV activity and/or structure homologs: contributing factors in the pathogenesis of rheumatoid arthritis?Optimal management of dactylitis in patients with psoriatic arthritisPeripheral blood gene expression patterns discriminate among chronic inflammatory diseases and healthy controls and identify novel targetsExercise increases interleukin-10 levels both intraarticularly and peri-synovially in patients with knee osteoarthritis: a randomized controlled trial.Tumour necrosis factor (TNF) in psoriatic arthritis: pathophysiology and treatment with TNF inhibitorsClinical significance of cytokine determination in synovial fluid.Mechanisms of TNF-alpha- and RANKL-mediated osteoclastogenesis and bone resorption in psoriatic arthritis.The Th17 axis in psoriatic disease: pathogenetic and therapeutic implications.Long-term use of adalimumab in the treatment of rheumatic diseases.Effect of certolizumab pegol on signs and symptoms in patients with psoriatic arthritis: 24-week results of a Phase 3 double-blind randomised placebo-controlled study (RAPID-PsA).T Cells in Osteoarthritis: Alterations and Beyond.Effect of tumour necrosis factor blockers on radiographic progression of psoriatic arthritis: a systematic review and meta-analysis of randomised controlled trials.New insights into the role of T cells in pathogenesis of psoriasis and psoriatic arthritis.Angiogenic and inflammatory properties of psoriatic arthritis.Regulatory effects of zinc on cadmium-induced cytotoxicity in chronic inflammation.Alefacept treatment in psoriatic arthritis: reduction of the effector T cell population in peripheral blood and synovial tissue is associated with improvement of clinical signs of arthritis.The Infliximab Multinational Psoriatic Arthritis Controlled Trial (IMPACT): results of radiographic analyses after 1 year.Cytokine blockers in psoriatic arthritis.Immunoporosis: Immunology of Osteoporosis-Role of T Cells.
P2860
Q24813111-6C10D5F5-4CFF-4E71-9F32-4D0768B37BA3Q28072557-BC897605-34A2-4D9B-9B59-A4969A848CCFQ33869998-A3FD866A-C755-4F31-84B4-1FC24BF381A1Q34152911-88102A22-5E23-46F2-86A1-C6DB1DE0DA7CQ34550167-303B2367-F47C-4588-84CF-AB71C5549395Q34559795-37A1429E-DAC5-4037-A584-339823163AF1Q34967810-AB9AF969-FB63-4E49-93BE-A398F3EACBE9Q35308947-9BED9D7C-9320-4F2F-AE8C-8D6E90F8F8C6Q37358124-7FB6A1AD-CCBD-40A3-AE89-ECEB466FAC1AQ37465550-F069A15C-6AD9-456E-B690-CB86DE29BE9FQ37727495-4CA1848D-5BF3-404F-BAC6-09DF791FD614Q38077142-9CC93C0A-4FE7-4C9A-B6A0-8CAEC5D9CAA3Q38799600-83FED31B-6A9C-4891-8733-DC6A8CBADAF0Q42156810-FD1B4F7A-9D72-4413-BB13-541820D2F1CEQ42337048-6FF22722-6FD8-4910-B3B4-0357B99B4F91Q42685943-109ACE71-4082-42EA-8953-57E4207CB8BFQ42955715-460699E4-DA87-4949-998B-1176BA2277F8Q43018087-71DEAD13-1B8C-4A42-9777-253AD68EEF5FQ52576095-8D9D7886-DA0A-40EB-BF37-83983CD8A989
P2860
T cell derived cytokines in psoriatic arthritis synovial fluids.
description
1998 nî lūn-bûn
@nan
1998 թուականի Նոյեմբերին հրատարակուած գիտական յօդուած
@hyw
1998 թվականի նոյեմբերին հրատարակված գիտական հոդված
@hy
1998年の論文
@ja
1998年論文
@yue
1998年論文
@zh-hant
1998年論文
@zh-hk
1998年論文
@zh-mo
1998年論文
@zh-tw
1998年论文
@wuu
name
T cell derived cytokines in psoriatic arthritis synovial fluids.
@ast
T cell derived cytokines in psoriatic arthritis synovial fluids.
@en
type
label
T cell derived cytokines in psoriatic arthritis synovial fluids.
@ast
T cell derived cytokines in psoriatic arthritis synovial fluids.
@en
prefLabel
T cell derived cytokines in psoriatic arthritis synovial fluids.
@ast
T cell derived cytokines in psoriatic arthritis synovial fluids.
@en
P2093
P356
P1476
T cell derived cytokines in psoriatic arthritis synovial fluids.
@en
P2093
P304
P356
10.1136/ARD.57.11.691
P407
P577
1998-11-01T00:00:00Z